Last reviewed 2026-05-23 · How we verify

TRIACETYLDIPHENOLISATIN

FDA-approved withdrawn Small molecule ✓ Verified May 2026 Quality 0/100

TRIACETYLDIPHENOLISATIN is a drug. It is currently FDA-approved.

Triacetyldiphenolisatin is a small molecule with an unknown mechanism of action. It is also known by the synonyms phenisatin, trisatin.

At a glance

Generic name	TRIACETYLDIPHENOLISATIN
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TRIACETYLDIPHENOLISATIN CI brief — competitive landscape report
TRIACETYLDIPHENOLISATIN updates RSS · CI watch RSS

Frequently asked questions about TRIACETYLDIPHENOLISATIN

What is TRIACETYLDIPHENOLISATIN?

TRIACETYLDIPHENOLISATIN is a Small molecule drug.

What development phase is TRIACETYLDIPHENOLISATIN in?

TRIACETYLDIPHENOLISATIN is FDA-approved (marketed).

Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing